Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Aquestive Therapeutics, Inc. (AQST) Class Action Lawsuit (March 2026)

In Litigation

3:26cv2317 • March 5, 2026

Class Period Start

June 16, 2025

Class Period End

January 8, 2026

PSLRA Deadline

May 4, 2026

Case Allegations

10b5

Statutes of Repose

Jun 16, 2028

Country

United States

Court

Federal Court

Docket History

Mar 5, 2026

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Aquestive Therapeutics, Inc..

TOP